Mohammad Khalaj-Kondory

22PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cancer diagnosisEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 21, 2026
Target therapeutic exploitation of engineered exosome-mediated delivery of ncRNAs in cancer.

|Apr 16, 2026
Epithelial-mesenchymal transition and its role in drug resistance of cervical cancer.

|Mar 04, 2026
A different perspective on the cancer stem cell theory.

Arezu Karimpur-Zahmatkesh, Mohammad Khalaj-Kondori

|Jan 27, 2026
Correlation of miR-214, miR-204, miR-25, miR-15a Expression with IL-33 and Malondialdehyde in Blood Samples from Patients with Alzheimer's Disease.

Haydar Sahib Almawashee, Mohammad Khalaj-Kondori, Mohammad Ali Hosseinpour Feizi

|Jun 30, 2025
Inhibition of CD133 resulted in cell death, inhibition of angiogenesis, and limited migration in the melanoma cancer cell line.

Farnaz Amini, Mohammad Khalaj-Kondori, Behzad Baradaran

|Jan 09, 2025
Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers.

Atabak Naiyeri, Amin Moqadami, Mohammad Khalaj-Kondori

Pageof 4

Frequent Collaborators

6 joint publications

Amin Moqadami

4 joint publications

Mohammad Ali Hosseinpour Feizi

3 joint publications

Mehdi Haghi

3 joint publications

Abedeh Rezaei